Abbott Receives CE Mark for TECNIS® Symfony Extended Range of Vision
Intraocular Lens for Cataract Patients
ABBOTT PARK, Illinois, June 24, 2014
ABBOTT PARK, Illinois, June 24, 2014 /PRNewswire/ -- Abbott (NYSE: ABT)
announced today it has received CE Marking (Conformite Europeenne) in Europe
for the TECNIS ^® Symfony Extended Range of Vision intraocular lens (IOL) for
the treatment of cataract patients who may also have a diminished ability to
focus on near objects (presbyopia). Standard IOLs can be used in cataract
treatment to improve distance vision, but the TECNIS Symfony IOL is a
first-of-its kind lens that is intended to provide patients a continuous range
of vision including far, intermediate and near distances with reduced
incidence of halo and glare comparable to a monofocal lens ^1 . This IOL is
not approved for use in the United States.
As the European population continues to age, the number of cataract surgeries
is expected to grow faster than the population growth. Patients who suffer
from diminished vision from cataracts may turn to surgery at younger ages due
to raised expectations of post-surgical outcomes. This may increase patient
demand for improved, precise vision and independence from eyeglasses.
In 2013, approximately 3.5 million cataract surgeries were performed in Europe
^2 , making it one of the most common surgical procedures. Abbott is focused
on developing products that can provide patients with clear vision at all
distances after cataract surgery to help them maintain active, healthy
"With the available advances in IOL technology, many patients are not
satisfied with having to wear reading glasses after cataract surgery, which is
often the result when using conventional monofocal IOLs," said Gerd U.
Auffarth, M.D., professor and chairman, Department of Ophthalmology,
Ruprecht-Karls University of Heidelberg, Germany. "The TECNIS Symfony Extended
Range of Vision IOL enables physicians to offer patients a continuous range of
functional vision for far, intermediate and near distances, with reduced risk
of undesired halos or glare."
The TECNIS Symfony extended range of vision IOL is designed to be placed in
the lens capsule of the eye to replace the natural crystalline lens that has
been removed because of a cataract. It is the first and only
presbyopia-correcting extended range of vision IOL designed to provide
patients increased independence from eyeglasses and quality vision over a
continuous range of distance including far, intermediate and near. This
innovative IOL is designed to increase the distance over which an object
appears in focus without sacrificing the patient's visual clarity or contrast
when compared with standard monofocal IOLs that provide improved distance
"The TECNIS Symfony Extended Range of Vision IOL represents the latest
advancement in cataract technology and expands Abbott's portfolio of the
TECNIS family of IOLs," said Murthy Simhambhatla, Ph.D., senior vice
president, Medical Optics, Abbott. "This new IOL demonstrates Abbott's
consistent innovation in bringing new treatment options to market, enabling
physicians to offer their patients clear vision after cataract surgery."
Abbott has commenced a 150-patient study in Europe to evaluate patients'
quality of vision at far, intermediate and near distances after being
implanted in both eyes with the TECNIS Symfony Extended Range of Vision IOL.
The study will also assess both patient and surgeon satisfaction. Preliminary
study results are anticipated later this year. Abbott is also conducting a
post-market observational study with approximately 400 patients across Europe,
including the United Kingdom, France, Germany and Spain, with results expected
at the end of 2014.
Abbott is a worldwide leader in the overall cataract segment with its TECNIS
line of monofocal, multifocal, and toric IOLs and the WHITESTAR Signature ^®
phacoemulsification lens removal system.
Click here for more information, including important safety information.
About Abbott Medical Optics (AMO)
Abbott Medical Optics is focused on delivering life-improving vision
technologies to people of all ages. The company offers a comprehensive
portfolio of cataract, refractive and eye care products. Products in the
cataract line include laser cataract technology, monofocal and multifocal
intraocular lenses (IOLs), phacoemulsification systems, viscoelastics, and
related products used in ocular surgery. Products in the refractive line
include wavefront diagnostic devices, femtosecond lasers and associated
patient interface devices; excimer laser vision correction systems and
treatment cards. Products in the eye care line include disinfecting solutions,
enzymatic cleaners, lens rewetting drops and artificial tears. For more
information, please visit http://www.abbottmedicaloptics.com .
Abbott is a global healthcare company devoted to improving life through the
development of products and technologies that span the breadth of healthcare.
With a portfolio of leading, science-based offerings in diagnostics, medical
devices, nutritionals and branded generic pharmaceuticals, Abbott serves
people in more than 150 countries and employs approximately 69,000 people.
Visit Abbott at www.abbott.com and connect with us on Twitter at @AbbottNews.
1. 166, Data on File. Extended Range of Vision IOL 3-Month Study Results (NZ).
2. 2013 Comprehensive Report on the Global IOL Market, Market Scope®, LLC
Contact: Media, Jonathon Hamilton, +1 (847) 935-8646, or Dan Wawrzyn, +1 (714)
247-8692, or Financial, Tina Ventura, +1 (847) 935-9390
Press spacebar to pause and continue. Press esc to stop.